Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 101.20M | £ 80.60M | £ 92.50M | £ 62.20M | £ 51.40M |
Total Assets | £ 1.48B | £ 1.35B | £ 1.35B | £ 1.30B | £ 592.50M |
Total Debt | £ 76.00M | £ 90.70M | £ 98.70M | £ 99.10M | £ 89.30M |
Net Debt | £ -25.20M | £ 10.10M | £ 6.20M | £ 36.90M | £ 37.90M |
Total Liabilities | £ 334.60M | £ 335.90M | £ 336.30M | £ 292.90M | £ 183.60M |
Stockholders Equity | £ 1.14B | £ 1.01B | £ 1.01B | £ 1.00B | £ 408.90M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |